BMC Immunology

Section Editors

Simon R Carding, University of Leeds
Lucienne Chatenoud, Hospital Necker
Olivier Garraud, EFS Auvergne - Loire
Catherine M Hawrylowicz, King's College London
James Li, University of Hong Kong
Juan Carlos Zuniga-Pflucker, University of Toronto

Executive Editor

Christopher Morrey, BioMed Central

Editorial Board | Editorial Team | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

Immunobiotics protect against Respiratory Syncytial Virus

Comparative studies using two Lactobacillus rhamnosus strains demonstrate that nasal administration of immunobiotics beneficially modulate immune responses in the respiratory tract and increase resistance to Respiratory Syncytial Virus challenge in mice.

BMC Immunology 2013, 14:40
CTLA4-Ig therapy modulates T cell effector function

Immunological study of T cell functionality in rheumatoid arthritis patients, both ACPA-positive and ACPA-negative, starting biological therapy with the co-stimulation blockade abatacept (CTLA4-Ig), supports the recently published registry study implicating ACPA seropositivity as an independent predictive factor to treatment response.

BMC Immunology 2013, 14:34
A regulatory role for microRNA in multiple sclerosis

Genome-wide expression analyses in T-cells from multiple sclerosis (MS) patients identifies multiple differentially expressed microRNAs that affect the expression of target genes associated with the immune system, suggesting a important regulatory role for microRNA in MS.

BMC Immunology 2013, 14:32
Effects of HCV virus co-infection on HIV patients on HAART

Immunological and clinical chemistry tests indicate that the improvement in CD4⁺ cell count of HIV/Hepatitis C (HCV) co-infected subjects under highly active antiretroviral therapy (HAART) is lower than HIV mono-infected individuals but that mono-infected patients respond better to HAART.

BMC Immunology 2013, 14:23
Elucidating the effects of IL-17 on neural stem cells

Mouse neural stem cells express Interleukin-17 (IL-17) receptors and treatment with IL-17 reduces neurosphere formation, cell number, proliferation and differentiation suggesting they may play a role in inducing demyelination and blocking neuronal repair in autoimmune disease.

BMC Immunology 2013, 14:20
View more articles

Latest review

Review

Olivier Garraud, Gwenoline Borhis, Gamal Badr, Séverine Degrelle, Bruno Pozzetto, Fabrice Cognasse and Yolande Richard

BMC Immunology 2013, 13:63 (29 November 2012)

Abstract | Full text | PDF | PubMed

RSS

Comments

raises a question ...

Comment on: Weinstein et al. BMC Immunology 2010, 11:23
Prerequisites for cytokine measurements

Comment on: de Jager et al. BMC Immunology 2009, 10:52
RT-PCR does not distinguish IL-4 mRNA from the IL-4R...

Comment on: Boeuf et al. BMC Immunology 2005, 6:5

Hot topic

DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice

Cao J, Jin Y, Li W, Zhang B, He Y, Liu H, Xia N, Wei H et al.

BMC Immunology 2013, 14:39

RSS

News from the web

02 October 2013: Mutant protein blocks HIV infection

02 October 2013: Exposure to a farming environment may prevent or dampen hypersensitivities and allergies

01 October 2013: Immune cells identified that promote growth of beta cells in type 1 diabetes

Scope

BMC Immunology is an open access journal publishing original peer-reviewed research articles in molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system as well as clinical studies and animal models of human diseases.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Join the Editorial Board!

Are you interested in becoming an Editorial Board member for BMC Immunology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmcimmunol@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.

RSS

BMC series blog

25 September 2013: BMC and the Royal College of General Practitioners

19 September 2013: Enhancing sexual health services through E-health technology

19 September 2013: Promoting respiratory health in Europe: a lot achieved, still more to do – ERS 2013

Section Editor's profile

Olivier Garraud is currently Professor of Immunology at the University of Lyon (the Faculty of Medicine of Saint-Etienne). Dr Garraud graduated as a physician and was trained in haematology and infectious diseases. He pursued his early career at the Institut Pasteur in Paris where he became involved with fundamental immunology. After more than a decade at the Institut Pasteur, Dr Garraud moved back to the field of medicine and was appointed the Executive Director of one of the 14 regional settings of the National Blood Service in France. Dr Garraud is currently supervising research programs focused on non-conventional B cell biology and platelet immunology in transfusion medicine but also in pathology, especially in infectious diseases such as sepsis, HIV infection and more generally in inflammation. Read more about his research interests in his recent review article.

"BMC Immunology is devoted to publishing high quality research in various directions in this fast growing discipline. We work hard to solicit the best possible reviewers and provide you with timely feedback in order to offer high visibility to important findings in the vast field of Immunology."